hec96719
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 30, 2020 (NCT04194242)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05397379 | Phase 2 | Nov 15, 2021 | Southern Medical University, Sunshine Lake Pharma Co., Ltd. |
| NCT04546984 | Phase 1 | Sep 14, 2020 | Sunshine Lake Pharma Co., Ltd. |
| NCT04422496 | Phase 1 | Aug 10, 2020 | Sunshine Lake Pharma Co., Ltd. |
| NCT04194242 | Phase 1 | Jan 30, 2020 | Sunshine Lake Pharma Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd. | For profit | 4 | 4 | 2 | 2020 |
| Southern Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1